GREGORINI, MARILENA
 Distribuzione geografica
Continente #
NA - Nord America 1.842
EU - Europa 1.483
AS - Asia 717
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
SA - Sud America 1
Totale 4.050
Nazione #
US - Stati Uniti d'America 1.834
CN - Cina 700
IE - Irlanda 615
UA - Ucraina 218
FI - Finlandia 139
SE - Svezia 131
IT - Italia 124
DE - Germania 122
GB - Regno Unito 57
BE - Belgio 52
FR - Francia 15
IN - India 10
CA - Canada 7
EU - Europa 4
KR - Corea 3
GR - Grecia 2
LV - Lettonia 2
MU - Mauritius 2
NL - Olanda 2
RU - Federazione Russa 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BR - Brasile 1
ES - Italia 1
HK - Hong Kong 1
IR - Iran 1
MX - Messico 1
Totale 4.050
Città #
Dublin 613
Chandler 450
Jacksonville 264
Nanjing 208
Ashburn 155
Wilmington 91
Princeton 83
Nanchang 80
Lawrence 76
Beijing 74
Ann Arbor 72
Medford 72
Shenyang 67
Hebei 63
Changsha 53
Brussels 52
New York 50
Helsinki 44
Boardman 35
Jiaxing 35
Shanghai 32
Tianjin 26
Hangzhou 25
Woodbridge 24
Milan 17
Houston 16
Norwalk 15
Seattle 14
Pavia 13
Falls Church 12
Verona 12
Torino 11
Collegno 9
Des Moines 8
Kunming 8
Lecce 8
Washington 8
Auburn Hills 7
Fairfield 7
Toronto 7
Jinan 6
Cernusco sul Naviglio 4
Dearborn 4
Falkenstein 4
Genova 4
Bangalore 3
Detroit 3
Gallarate 3
Guangzhou 3
Ningbo 3
Pune 3
Seongnam-si 3
Athens 2
Atlanta 2
Bergamo 2
Borås 2
Boves 2
Brescia 2
Changchun 2
Los Angeles 2
Orange 2
Pedrengo 2
Taizhou 2
Tappahannock 2
Taranto 2
Berlin 1
Cedar Knolls 1
Central 1
Chicago 1
Cologno Al Serio 1
Edmond 1
Frosinone 1
Gravina di Catania 1
Gustavo Adolfo Madero 1
Hanover 1
Jaipur 1
London 1
Messina 1
Montesilvano Marina 1
Novokuznetsk 1
Padova 1
Redmond 1
Redwood City 1
Rome 1
San Jose 1
Santa Clara 1
Saronno 1
Sasso Marconi 1
Tomsk 1
Tortosa 1
Vienna 1
Zhengzhou 1
Totale 3.012
Nome #
Costimulatory Pathways in Kidney Transplantation: Pathogenetic Role, Clinical Significance and New Therapeutic Opportunities. 93
Multiple electrolyte disorders in a neurosurgical patient: solving the rebus. 90
Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis Treated With Autologous Mesenchymal Stromal Cells: Evaluation of the Contribution of Immune-Mediated Mechanisms. 82
Macrophage stimulating protein (MSP) determina proliferazione e migrazione delle cellule mesangiali 82
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation. 82
[The usefulness of protocol biopsies after kidney transplant: pros and cons]. 80
KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells. 78
Autoimmune response to heat shock protein 60 in haemodialysis patients 74
Hemodialysis stimulates the injurins-hepatocyte growth factor release 73
GM-CSF contributes to prompt healing of ecthyma gangrenosum lesions in kidney transplant recipient. 71
Erythema nodosum in kidney transplant recipient: a rare complication of pneumonia treatment. 71
Scabies crustosa in a 61-year-old kidney-transplanted patient. 68
Macrophage stimulating protein is produced by tubular cells and activates mesangial cells 68
Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. 68
Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation 67
Autoimmune response to heat shock protein 60 in haemodialysis patients 67
Hepatocyte growth factor protects the liver against hepatitis C virus in patients on regular hemodialysis. 67
The role of therapeutic drug monitoring in the treatment of cytomegalovirus disease in kidney transplantation. 65
Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial? 65
Atraumatic spleen rupture in dialyzed patients: clinical report and review of the literature. 65
Mechanisms underlying sCD40 production in hemodialysis patients. 63
Early allograft calcifications after kidney transplantation. 63
Severe symptomatic hyponatremia during sibutramine therapy: a case report. 62
Quiz page August 2009: Respiratory distress 5 years after kidney transplantation. 62
The role of antiglomerular autoantibodies in lupus nephropathy: a debate resolved? 61
Is it time to abandon renal biopsy 60
Urotensin II is related with atherogenic risk in hemodialysis patients 60
Renal diseases in haemophilic patients: pathogenesis and clinical management. 59
Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors 59
Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis 58
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells 57
Hepatocyte growth factor protects the liver against hepatitis C virus in patients on regular hemodialysis 56
Hemodialysis stimulates hepatocyte growth factor release. 55
[Non-heart-beating-donor transplant: the first experience in Italy]. 55
The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma 54
A retrospective analysis of dermatological lesions in kidney transplant patients. 54
Ganciclovir-resistant cytomegalovirus infection in transplanted patients: utility of drug monitoring. 53
Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factor 53
Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report 53
Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab 50
Hemodialysis stimulates hepatocyte growth factor release 49
L'emodialisi induce una variazione conformazionale della beta-2 microglobulina (B-2M) espressa sulla superficie dei leucociti circolanti 48
Huge kidneys in a patient with chronic lymphocytic leukaemia 47
Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor 46
KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells 46
Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR. 46
Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells. 46
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 46
Assessment of physical performance and quality of life in kidney-transplanted patients: A cross-sectional study 45
Myostatin in the arterial wall of patients with end-stage renal disease 44
[Donor and recipient selection in living donor kidney transplantation: eligibility] 42
Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injury 40
Psychological Aspects and Psychopharmacologic Treatment in the Very Early Period After Kidney Transplantation: Role of a Multidisciplinary Approach 40
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 40
Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factor 39
Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine 39
Global Performance Status Score: A New Tool to Assess Physical Performance in Kidney Transplant Patients 39
Early onset of graft glomerulopathy in a patient with post-transplant diabetes mellitus after renal transplantation: A case report 38
Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients 36
Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial 36
The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma 35
Characterization of varicella-zoster (Vzv) specific t cell response in healthy subjects and transplanted patients by using enzyme linked immunospot (elispot) assays 35
Mesenchymal stromal cells injection reduces acute rejection damage in a rat experimental model of kidney transplantation 34
Renal involvement in mushroom poisoning: The case of Orellanus syndrome 32
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities 32
Living Kidney Donation Is Recipient Age Sensitive and Has a High Rate of Donor Organ Disqualifications 31
Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia 31
Significance of serum Myostatin in hemodialysis patients 29
Liposome Formulation and In Vitro Testing in Non-Physiological Conditions Addressed to Ex Vivo Kidney Perfusion 28
Understanding Bone Damage After Kidney Transplantation: A Retrospective Monocentric Cross Sectional Analysis 28
Psychiatric and psychological evaluation in living donor kidney transplantation: a single center experience 28
Early allograft calcifications after kidney transplantation 27
Extracellular Vesicles Derived from Mesenchymal Stromal Cells Delivered during Hypothermic Oxygenated Machine Perfusion Repair Ischemic/Reperfusion Damage of Kidneys from Extended Criteria Donors 27
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients 26
CD73-Adenosinergic Axis Mediates the Protective Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Ischemic Renal Damage in a Rat Model of Donation after Circulatory Death 26
Nuclear Amyloid Fibrils Detected in Human SH-SY5Y Cells in Presence of Aβ1-42 and LPS 25
Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy 25
Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure 24
Robot-Assisted Harvesting of Kidneys for Transplantation and Global Complications for the Donor 24
Neutralization of macrophage stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis. 23
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation 22
Scatter Factors in renal disease: Dr.Jeckyll and Mr. Hyde? 21
Photopheresis abates the anti-hla antibody titer and renal failure progression in chronic antibody-mediated rejection 18
SARS-CoV-2-specific IgG and NCP in vulnerable patients without symptoms 15
Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant 14
The innate immune system in human kidney inflammaging 12
Performance of Whole Blood Stimulation Assays for the Quantification of SARS-CoV-2 Specific T-Cell Response: A Cross-Sectional Study 11
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 10
Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammaging 10
null 7
Liposome Formulation and In Vitro Testing in Non-Physiological Conditions Addressed to Ex Vivo Kidney Perfusion 7
ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients 5
Totale 4.197
Categoria #
all - tutte 14.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 6 1 9
2019/2020866 246 323 7 42 2 46 6 43 26 83 37 5
2020/2021497 48 38 28 59 9 70 8 65 31 65 57 19
2021/2022410 13 0 6 5 54 14 12 13 25 11 56 201
2022/20231.468 118 89 15 136 117 133 3 74 719 15 33 16
2023/2024440 55 69 24 40 41 129 17 62 3 0 0 0
Totale 4.197